418 related articles for article (PubMed ID: 21220596)
1. Colorectal cancer epigenetics: complex simplicity.
van Engeland M; Derks S; Smits KM; Meijer GA; Herman JG
J Clin Oncol; 2011 Apr; 29(10):1382-91. PubMed ID: 21220596
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic biomarkers of colorectal cancer: Focus on DNA methylation.
Coppedè F
Cancer Lett; 2014 Jan; 342(2):238-47. PubMed ID: 22202641
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics of colorectal cancer.
Migheli F; Migliore L
Clin Genet; 2012 Apr; 81(4):312-8. PubMed ID: 22263639
[TBL] [Abstract][Full Text] [Related]
4. Pathogenetic and clinical relevance of microRNAs in colorectal cancer.
Valeri N; Croce CM; Fabbri M
Cancer Genomics Proteomics; 2009; 6(4):195-204. PubMed ID: 19656996
[TBL] [Abstract][Full Text] [Related]
5. Targeting aberrant chromatin structure in colorectal carcinomas.
Konishi K; Issa JP
Cancer J; 2007; 13(1):49-55. PubMed ID: 17464246
[TBL] [Abstract][Full Text] [Related]
6. Cancer epigenetics.
Taby R; Issa JP
CA Cancer J Clin; 2010; 60(6):376-92. PubMed ID: 20959400
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation and colorectal cancer.
Matsubara N
Dis Colon Rectum; 2012 Jan; 55(1):96-104. PubMed ID: 22156874
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic biomarkers in colorectal cancer diagnostics.
Rawson JB; Bapat B
Expert Rev Mol Diagn; 2012 Jun; 12(5):499-509. PubMed ID: 22702366
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility genetic variants associated with colorectal cancer risk correlate with cancer phenotype.
Abulí A; Bessa X; González JR; Ruiz-Ponte C; Cáceres A; Muñoz J; Gonzalo V; Balaguer F; Fernández-Rozadilla C; González D; de Castro L; Clofent J; Bujanda L; Cubiella J; Reñé JM; Morillas JD; Lanas A; Rigau J; García AM; Latorre M; Saló J; Fernández Bañares F; Argüello L; Peña E; Vilella A; Riestra S; Carreño R; Paya A; Alenda C; Xicola RM; Doyle BJ; Jover R; Llor X; Carracedo A; Castells A; Castellví-Bel S; Andreu M;
Gastroenterology; 2010 Sep; 139(3):788-96, 796.e1-6. PubMed ID: 20638935
[TBL] [Abstract][Full Text] [Related]
10. [Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].
Lakatos PL; Lakatos L
Orv Hetil; 2006 Mar; 147(10):449-55. PubMed ID: 16573174
[TBL] [Abstract][Full Text] [Related]
11. The role of epigenetics in colorectal cancer.
Coppedè F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer epigenetics: the role of environmental factors and the search for molecular biomarkers.
Ahmed FE
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(2):101-54. PubMed ID: 17558783
[TBL] [Abstract][Full Text] [Related]
13. [Promoter hypermethylation and CpG island methylator phenotype in colorectal carcinogenesis].
Matsubara N
Gan To Kagaku Ryoho; 2010 Sep; 37(9):1659-64. PubMed ID: 20841928
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic biomarkers of colorectal cancer.
Choong MK; Tsafnat G
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):9-15. PubMed ID: 21635968
[TBL] [Abstract][Full Text] [Related]
15. Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers.
Goel A; Li MS; Nagasaka T; Shin SK; Fuerst F; Ricciardiello L; Wasserman L; Boland CR
Gastroenterology; 2006 Jun; 130(7):1950-61. PubMed ID: 16762618
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA in colorectal cancer: new perspectives for diagnosis, prognosis and treatment.
Bonfrate L; Altomare DF; Di Lena M; Travaglio E; Rotelli MT; De Luca A; Portincasa P
J Gastrointestin Liver Dis; 2013 Sep; 22(3):311-20. PubMed ID: 24078989
[TBL] [Abstract][Full Text] [Related]
17. [Colorectal carcinoma and DNA methylation].
Liu M; Shen S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1266-70. PubMed ID: 20045925
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation and chromatin modifiers in colorectal cancer.
Vymetalkova V; Vodicka P; Vodenkova S; Alonso S; Schneider-Stock R
Mol Aspects Med; 2019 Oct; 69():73-92. PubMed ID: 31028771
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of aberrant DNA methylation during colorectal cancer development.
Sakai E; Nakajima A; Kaneda A
World J Gastroenterol; 2014 Jan; 20(4):978-87. PubMed ID: 24574770
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic biomarkers in prostate cancer: Current and future uses.
Chiam K; Ricciardelli C; Bianco-Miotto T
Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]